View all dosages and compare prices:
💊 Buy Mounjaro — all dosages →Buy Mounjaro 5 mg
Active weight loss — base dose
in Ukraine · Original Eli Lilly (UK) · Thermobox delivery
💊 Try for 16 000 ₴/mo
4 individual doses instead of a full pen · save 3 500 ₴
Ships today · before 19:00
Delivery Sat, Jun 27 · Nova Poshta
Base Mounjaro pen 5 mg — first dose increase after adaptation. Active weight loss and sustained appetite reduction.
First increase after the starting dose. Sustained appetite reduction and gaining momentum.
Specialist support included in the price
A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.
DOZA offers the original UK version of Mounjaro 5 mg
Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Not Indian generics, not the US version (FDA), not Chinese copies. You can verify authenticity by the serial number on the packaging.
Why specifically the UK version? After incidents with DE and ES supply chains — where storage conditions were compromised and clients didn't achieve expected results — we chose exclusively the British Eli Lilly supply chain. It has the strictest post-Brexit transport controls for GLP-1 products.
Free specialist consultation
Benefits of Mounjaro 5 mg
- ✓Sustained appetite reduction — portions decrease naturally
- ✓Active weight loss phase: -5 to -8 kg from program start
- ✓Double effectiveness compared to starter dose
- ✓Original Eli Lilly product with verified serial number
- ✓Convenient KwikPen — once weekly
- ✓Delivery with cold chain compliance across Ukraine
Mounjaro 5 mg — detailed description
Mounjaro 5 mg is the base tirzepatide dose patients transition to after successful adaptation on 2.5 mg (weeks 5-8). At this dose, the active weight loss phase begins.
Dual GLP-1 + GIP action at 5 mg dose provides sustained appetite reduction. Most clients notice that portions become smaller naturally — without effort and strict diets.
According to the SURMOUNT-1 study, at 5 mg dose participants lost an average of 15% of body weight over 72 weeks. DOZA clients on 5 mg typically achieve -5 to -8 kg from the start of the program.
How Mounjaro 5 mg works — tirzepatide mechanism of action
At 5 mg dose, tirzepatide significantly enhances effects on both receptors:
• GLP-1 receptors: more powerful appetite suppression, sustained satiety after small portions
• GIP receptors: active mobilization of fat stores as energy source
• Delayed gastric transit ensures prolonged satiety after meals
The transition from 2.5 mg to 5 mg doubles the dose, so some clients may experience mild nausea for the first 1-2 days, which quickly subsides.
Clinical research
Mounjaro (tirzepatide 5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.
- SURMOUNT-1: Tirzepatide once weekly for the treatment of obesity (NEJM 2022)PubMed · 2022
- SURPASS-2: Tirzepatide vs semaglutide in type 2 diabetes (NEJM 2021)PubMed · 2021
- FDA prescribing information — Mounjaro (tirzepatide)FDA prescribing information · 2022
Titration protocol to 5 mg (tirzepatide)
Starting dose — GI adaptation
First therapeutic dose
Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 5 mg: 7–8% over 40 weeks (based on clinical studies).
Who is Mounjaro 5 mg for
- First therapeutic dose — weight loss effect is already noticeable
- Patients who tolerate 2.5 mg well without side effects
- Standard maintenance dose for mild excess weight (BMI 27–30)
Mounjaro 5 mg — compared to other doses
- 5 mg is the minimum effective dose for weight loss
- Average weight loss: ~7–8% over 40 weeks (SURMOUNT-1)
- If the target weight is not reached — increase to 7.5 mg after ≥4 weeks
Frequently asked questions about Mounjaro 5 mg
The transition from 2.5 mg to 5 mg occurs after 4 weeks from program start, if the starter dose was well tolerated. A DOZA specialist will assess your response and confirm the dose increase.
Anastasia Shapoval
Metabolic Programs and Weight Control Specialist
Weight loss program — step-by-step dose escalation
DOZA client reviews for Mounjaro 5 mg
Mounjaro 5 mg — felt results in 3 weeks. Lost 4 kg in the first month. Thermobox delivery, excellent quality. DOZA — support throughout the entire course.
Ordering Mounjaro 5 mg for the second time. Original Eli Lilly quality, fair price. DOZA — highly recommend.
All Mounjaro client results →
Before/after photos · numbers · timelines · reviews
Other Mounjaro dosages
Mounjaro 5 mg — buy in Ukraine from DOZA
Mounjaro 5 mg (Mounjaro 5 mg, tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 19 500 ₴ (≈ 4 875 ₴ per injection). Buy Mounjaro 5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).
Why does DOZA only work with the UK version? We stopped working with DE and ES versions after cases when clients didn't achieve expected results — likely due to storage condition violations during transport. The UK supply chain of Eli Lilly has the strictest quality control among European markets. Each KwikPen has a serial number verifiable on the manufacturer's official website.
Mounjaro 5 mg is suitable for weeks 5-8 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.
DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.
⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.
